Target intelligence / Profile preview

G protein-coupled receptor 15 ligand (GPR15LG)

Target
GPR15LG
Molecular classification
Endogenous peptide, Chemokine-like peptide, Ligand, GPCR ligand, Antimicrobial peptide
01

Overview

G protein-coupled receptor 15 ligand (GPR15LG, also known as C10orf99 or GPR15L) is a highly cationic, small, endogenous human peptide with multiple biological activities. It acts as a chemokine-like ligand for the orphan G protein-coupled receptor GPR15, mediating lymphocyte recruitment to epithelial barriers, including the colon and skin. GPR15LG is also notable for its direct antimicrobial activity against Gram-positive bacteria, mast cell activation via MRGPRs (contributing to pruritus), and potential tumor suppressor effects in colon cancer (possibly via growth inhibition and cell cycle arrest in cooperation with SUSD2). Structurally, GPR15LG is predicted to have two intramolecular disulfide bonds and shares similarities with CC family cytokines.

Other names
Protein GPR15LGC10orf99GPR15LUNQ1833/PRO3446AP-57Antimicrobial peptide-57CSBFRLLV1833FLJ21763Colon-derived SUSD2 binding factorProtein GPR15 ligandProtein GPR15LSecreted protein C10orf99
02

Mechanism of action

As a ligand, activates the G protein-coupled receptor GPR15 (agonist) Activates Mas-related G protein-coupled receptors (MRGPRs) to induce mast cell degranulation and pruritus (itch), independent of GPR15

03

Biological functions

Chemokine activity (induces chemotaxis, especially of lymphocytes)Lymphocyte recruitment to epithelia via GPR15 activationNegative regulation of cell cycle G1/S phase transitionDefense response to Gram-positive bacteriaMast cell degranulation and pruritogenesis (itch sensation)Growth inhibition in colon cancer cells (with SUSD2)Regulation of keratinocyte proliferation
04

Disease associations

Cancer (potential tumor suppressor in colon cancer)Infection (antimicrobial activity)Inflammation (pruritogen and mast cell degranulation)Other: associated with conjunctival nevus, pachyonychia congenita 1
05

Safety considerations

No prominent therapeutic safety concerns reported to date; main research focus is on biology and mechanism rather than therapeutic modulation
06

Biomarkers

None currently established for patient selection; expression may correlate with epithelial, immune, or oncological conditions under investigation

Beyond the preview

Go deeper on G protein-coupled receptor 15 ligand (GPR15LG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on G protein-coupled receptor 15 ligand (GPR15LG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call